The best question Common Stocks and Uncommon Profits ( one of the all-time-great investment books) asks companies:
What are you doing that your competitors aren’t, yet ?
For Gufic, it was lyophilised injectables at one time where the industry seems to now moving. In the future what do you think that it could be?
They spend 8-10% of revenue in R&D but judging future R&D is perhaps too difficult for a lay investor. (Scuttlebutt HELP!). What factors does this community think it could be for Gufic to give better growth than the industry?
| Subscribe To Our Free Newsletter |
